Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents

American Journal of Roentgenology

Volumn 195, Issue 2, 2010, Pages 405-413

  Gupta, Rajan T ^a   Brady, Christopher M ^a   Lotz, Joachim ^b   Boll, Daniel T ^a   Merkle, Elmar M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Hepatobiliary system; Hepatocyte specific MR contrast agents; MRI

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM; CONTRAST MEDIUM;

HEPATOBILIARY SYSTEM; LIVER CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; BILIARY TRACT DISEASE; DIAGNOSTIC USE; DRUG DELIVERY SYSTEM; HUMAN; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES;

BILIARY TRACT; BILIARY TRACT DISEASES; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; GADOLINIUM; HEPATOCYTES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING;

EID: 77955618038     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.09.3641     Document Type: Review

References (14)

1. Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009; 19:342-357
2. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2004; 14:559-578 (Pubitemid 38444568)
3. Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol 2007; 48:362-368 (Pubitemid 46633865)
4. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996; 200:59-67 (Pubitemid 26197732)
5. Frericks BB, Loddenkemper C, Huppertz A, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR 2009; 193:1053-1060
6. Carlos RC, Hussain HK, Song JH, Francis IR. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR 2002; 179:87-92
7. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195:785-792
8. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 2002; 9:1322-1325 (Pubitemid 35265403)
9. Lim JS, Kim MJ, Jung YY, Kim KW. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction. Korean J Radiol 2005; 6:229-234
10. Petersein J, Spinazzi A, Giovagnoni A, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging - a multicenter phase III clinical study. Radiology 2000; 215:727-736 (Pubitemid 30346007)
11. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary- specific MR contrast agents: role in imaging the liver and biliary tree. RadioGraphics 2009; 29:1725-1748
12. Nagle SK, Busse RF, Brau AC, et al. High-resolution free-breathing 3D T1 weighted hepatobiliary imaging optimized for Gd-EOB-DTPA. (abstr) Proc Intl Soc Mag Reson Med 2009; 17:2076
13. Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. RadioGraphics 2009; 29:1707-1724
14. Akpinar E, Turkbey B, Karcaaltincaba M, et al. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis. J Magn Reson Imaging 2009; 30:578-585